-
EP3329896
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3329896
| EP3329896 - TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.03.2023 Database last updated on 06.11.2024 | |
| Former | Examination is in progress Status updated on 07.04.2020 | ||
| Former | Request for examination was made Status updated on 19.10.2018 | ||
| Former | The application has been published Status updated on 04.05.2018 | Most recent event Tooltip | 10.03.2023 | Application deemed to be withdrawn | published on 12.04.2023 [2023/15] | Applicant(s) | For all designated states Allergan, Inc. 2525 Dupont Drive Irvine, CA 92612 / US | [2018/23] | Inventor(s) | 01 /
Gore, Anuradha V. 8 Del Rey Irvine, CA California 92612 / US | 02 /
Shankar, Sai 2404 Spectrum Irvine, CA California 92618 / US | 03 /
Likitlersuang, Sukhon 611 Wycliffe Irvine, CA California 92602 / US | 04 /
Pujara, Chetan P. 6 Wheeler Irvine, CA California 92620 / US | 05 /
Neervannan, Sesha 32 Trailing Ivy Irvine, CA California 92656 / US | [2018/23] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [2018/23] | Application number, filing date | 18151604.8 | 26.07.2012 | [2018/23] | Priority number, date | US201161511753P | 26.07.2011 Original published format: US 201161511753 P | [2018/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3329896 | Date: | 06.06.2018 | Language: | EN | [2018/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 12.04.2018 | Classification | IPC: | A61J1/00, A61K9/00, B65D81/32, A61K47/34, A61K38/13, A61K9/08, A61K31/568, A61K31/417, A61K31/559, A61K31/4025 | [2018/23] | CPC: |
A61K38/13 (EP,US);
A61K31/4025 (EP,US);
A61K31/417 (EP,US);
A61K31/559 (EP,US);
A61K31/568 (EP,US);
A61K47/02 (US);
A61K47/12 (US);
A61K47/18 (US);
A61K47/26 (US);
A61K47/34 (EP,US);
A61K47/40 (US);
A61K9/0048 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/47] |
| Former [2018/23] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | SYSTEM MIT EINER ZWEITEILIGEN FORMULIERUNG ZUR OPHTHALMISCHEN VERABREICHUNG | [2018/23] | English: | TWO PART FORMULATION SYSTEM FOR OPHTHALMIC DELIVERY | [2018/23] | French: | SYSTÈME DE FORMULATION EN DEUX PARTIES POUR ADMINISTRATION OPHTALMIQUE | [2018/23] | Examination procedure | 14.08.2018 | Amendment by applicant (claims and/or description) | 16.10.2018 | Examination requested [2018/47] | 16.10.2018 | Date on which the examining division has become responsible | 14.04.2020 | Despatch of a communication from the examining division (Time limit: M06) | 26.10.2020 | Reply to a communication from the examining division | 03.05.2022 | Despatch of a communication from the examining division (Time limit: M06) | 15.11.2022 | Application deemed to be withdrawn, date of legal effect [2023/15] | 06.12.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/15] | Parent application(s) Tooltip | EP12762425.2 / EP2736475 | Fees paid | Renewal fee | 15.01.2018 | Renewal fee patent year 03 | 15.01.2018 | Renewal fee patent year 04 | 15.01.2018 | Renewal fee patent year 05 | 15.01.2018 | Renewal fee patent year 06 | 27.07.2018 | Renewal fee patent year 07 | 29.07.2019 | Renewal fee patent year 08 | 27.07.2020 | Renewal fee patent year 09 | 27.07.2021 | Renewal fee patent year 10 | 11.07.2022 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]JPH0558906 (SANKYO CO); | [A]US5409904 (HECHT GERALD [US], et al); | [A]WO2009046967 (FOVEA PHARMACEUTICALS SA [FR], et al); | [I]WO2009088570 (SIRION THERAPEUTICS INC [US], et al); | Examination | US2009221984 |